SINT SINTX TECHNOLOGIES INC.

SINTX Technologies Receives Additional SBIR Contract for 3D Printing Technology 

SINTX Technologies Receives Additional SBIR Contract for 3D Printing Technology 

Salt Lake City, Utah., June 06, 2024 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (SINTX) () (NASDAQ: SINT; “SINTX” or the “Company”), a manufacturer and developer of advanced ceramic materials and related technologies, announced today that its wholly-owned subsidiary, Technology Assessment and Transfer, Inc. (TA&T) has been selected by AFWERX for a 3-month, $75,000, phase I Small Business Innovation Research (SBIR) contract focused on Enhanced Sinterability of Complex-Shaped 3D Printed Silicon Nitride (Si3N4). This contract will address material challenges in propulsion and guidance technology for next generation high-temperature Department of the Air Force systems.

The Air Force Research Laboratory (AFRL) and AFWERX have partnered to streamline the SBIR and STTR process by accelerating the small business experience. The DAF began offering the Open Topic SBIR/STTR program in 2018, and now, through this partnership, TA&T will expand its ability to create and provide innovative capabilities that will strengthen the defense of the United States of America. If successful, TA&T/SINTX will attempt to leverage this work into an AFWERX phase II contract worth up to $1.25M over 21 months.

Silicon nitride has very attractive mechanical, thermal, and dielectric properties that enable its use in aero-engine and microwave-frequency aperture applications. The latter is a strategic focus area across the SINTX family of companies. The combination of past projects in printing all-ceramic microwave polarization converters, current IR&D in compositional development for RF, plans for a future SBIR effort in compositional development for RF, and development of industrial partnerships for RF, all converge on the goal of TA&T/SINTX entering the RF market.

The current effort addresses the fact that although there is significant activity in 3D printing complex shapes of silicon nitride, industry has yet to demonstrate production of real silicon nitride parts meeting application-specific performance and repeatability. 3D printing silicon nitride presents unique technical challenges compared to other technical ceramics such as aluminum oxide, not only in the printing process, but also in the complicated thermal processing required after printing—especially in the step called “sintering” in which the material is consolidated into a high-density shape. SINTX is uniquely situated within this industry because of the company’s decades of experience with the silicon nitride material family and TA&T’s deep expertise in ceramic 3D printing.

David O’Brien, EVP and COO of SINTX, commented: “For over 15 years, SINTX has been the world-leader in the manufacturing and supply of silicon nitride components for spinal fusion devices. Beginning in 2018, we expanded our focus to address the broader technical ceramics market, including aerospace, defense, and energy applications. The 2022 acquisition of TA&T in Maryland brought into our portfolio over 25 years of ceramic additive manufacturing experience, and this SBIR award is just one example of our united team working together to develop novel solutions to longstanding industry challenges.”

The views expressed are those of the author and do not necessarily reflect the official policy or position of the Department of the Air Force, the Department of Defense, or the U.S. government. 

About SINTX Technologies, Inc. 

SINTX Technologies is an advanced ceramics company that develops and commercializes materials, components, and technologies for medical and technical applications. SINTX is a global leader in the research, development, and manufacturing of silicon nitride, and its products have been implanted in humans since 2008. Over the past several years, SINTX has utilized strategic acquisitions and alliances to enter into new markets. The Company has manufacturing facilities in Utah and Maryland.

About Air Force Research Laboratory (AFRL) 

The Air Force Research Laboratory is the primary scientific research and development center for the Department of the Air Force. AFRL plays an integral role in leading the discovery, development, and integration of affordable warfighting technologies for our air, space and cyberspace force. With a workforce of more than 12,500 across nine technology areas and 40 other operations across the globe, AFRL provides a diverse portfolio of science and technology ranging from fundamental to advanced research and technology development. For more information, visit .

About AFWERX 

As the innovation arm of the DAF and a directorate within the Air Force Research Laboratory, AFWERX brings cutting-edge American ingenuity from small businesses and start-ups to address the most pressing challenges of the DAF. AFWERX employs approximately 325 military, civilian and contractor personnel at six hubs and sites executing an annual $1.4 billion budget. Since 2019, AFWERX has executed 4,697 contracts worth more than $2.6 billion to strengthen the U.S. defense industrial base and drive faster technology transition to operational capability. For more information, visit: . 

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (PSLRA), including, but not limited to, statements regarding SINTX’s ability to leverage this work into an AFWERX phase II contract, effectively manufacture ceramic products, the market for and benefits of SINTX’s ceramic products, SINTX’s ability to effectively compete in the ceramic industry, and other statements that are not based on historical fact. Such forward-looking statements are subject to a number of risks and uncertainties that may cause actual results to differ from current expectations. Risks and uncertainties that may cause such differences include, among other things: SINTX’s products may not prove to be as effective as other products currently being commercialized or to be commercialized in the future by competitors; risks inherent in manufacturing and scaling up to commercial quantities while maintaining quality controls; volatility in the price of SINTX’s common stock; the uncertainties inherent in new product development, including the cost and time required to commercialize such product(s); market acceptance of our products once commercialized; SINTX’s ability to raise funding and other competitive developments. Readers are cautioned not to place undue reliance on the forward-looking statements, which speak only as of the date on which they are made and reflect management’s current estimates, projections, expectations and beliefs. There can be no assurance that any of the anticipated results will occur on a timely basis or at all due to certain risks and uncertainties, a discussion of which can be found in SINTX’s Risk Factors disclosure in its Annual Report on Form 10-K, filed with the Securities and Exchange Commission (SEC) on March 27, 2024, and in SINTX’s other filings with the SEC. SINTX disclaims any obligation to update any forward-looking statements. SINTX undertakes no obligation to publicly revise or update the forward-looking statements to reflect events or circumstances that arise after the date of this report.

Business and Media Inquiries for SINTX:

SINTX Technologies

801.839.3502



EN
06/06/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on SINTX TECHNOLOGIES INC.

 PRESS RELEASE

SINTX Technologies to Participate in Noble Capital Markets’ Emerging G...

SINTX Technologies to Participate in Noble Capital Markets’ Emerging Growth Virtual Equity Conference on February 4–5 SALT LAKE CITY, Utah, Jan. 29, 2026 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), an advanced ceramics and biomaterials company focused on silicon-nitride-based medical technologies, today announced that its management team will present at the Noble Capital Markets Emerging Growth Virtual Equity Conference, to be held February 4–5, 2026. The Company’s participation comes at an important stage in its evolution, following a period o...

 PRESS RELEASE

SINTX Technologies to Participate in Sidoti & Company Investor Confere...

SINTX Technologies to Participate in Sidoti & Company Investor Conference SALT LAKE CITY, Utah, Dec. 08, 2025 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), today announced that management will be presenting at Sidoti & Company’s Year End Virtual Investor Conference, held December 10-11, 2025. Sidoti's Year End Virtual Investor ConferenceDates: December 10-11, 2025Presentation Date and Time: Wednesday, December 10, 2025 at 3:15 P.M. ETWebcast: To schedule a one-on-one meeting with SINTX Technologies’ management team, please email KCSA Strategic ...

 PRESS RELEASE

SINTX Technologies unterzeichnet Liefervertrag mit EVONIK zur Herstell...

SINTX Technologies unterzeichnet Liefervertrag mit EVONIK zur Herstellung eines Siliziumnitrid-PEEK-Verbundwerkstoffes für KI-gestützte, 3D-gedruckte patientenspezifische Implantate Ein Meilenstein, der die sofortige Produktion von maßgefertigten SiN/PEEK-Implantaten ermöglicht SALT LAKE CITY, Utah, Dec. 01, 2025 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) („SINTX” oder das „Unternehmen”), ein Unternehmen für innovative Keramik und Biomaterialien, gab heute die Unterzeichnung eines Liefervertrags mit Evonik Corporation („EVONIK”), einem weltweit führenden Anbieter von Ho...

 PRESS RELEASE

SINTX Technologies firma un acuerdo de suministro con EVONIK para fabr...

SINTX Technologies firma un acuerdo de suministro con EVONIK para fabricar un compuesto de nitruro de silicio-PEEK para implantes específicos para el paciente, impresos en 3D y asistidos por IA El hito permite la producción inmediata de dispositivos personalizados de SiN/PEEK SALT LAKE CITY, Utah, Dec. 01, 2025 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” o la “Compañía”), una empresa de cerámicas avanzadas y biomateriales, anunció hoy que firmó un acuerdo de suministro con Evonik Corporation (“EVONIK”), líder global en polímeros de alto rendimiento, para fabricar...

 PRESS RELEASE

SINTX Technologies 與 EVONIK 簽署供應協議,生產用於人工智能輔助 3D 打印患者專屬植入物的氮化矽–PEEK 複合...

SINTX Technologies 與 EVONIK 簽署供應協議,生產用於人工智能輔助 3D 打印患者專屬植入物的氮化矽–PEEK 複合材料 此里程碑讓 SiN/PEEK 定制儀器得以即時投產 猶他州鹽湖城, Dec. 02, 2025 (GLOBE NEWSWIRE) -- 先進陶瓷與生物材料公司 SINTX Technologies, Inc. (NASDAQ: SINT) (「SINTX」或「該公司」) 今日宣佈,已與高性能聚合物全球領導者 Evonik Corporation (「EVONIK」) 簽署供應協議,生產該公司專利的氮化矽–PEEK(即聚醚醚酮)複合材料 (SiN/PEEK) (美國專利編號:10,806,831),此材料專為人工智能 (AI) 輔助增材製造患者專屬植入物而設計,將運用 SINTX 美國生產基地現有設備來生產。 根據協議,EVONIK 將發揮達到商業規模的生產能力,按照 SINTX 規格生產 SiN/PEEK 複合材料,使該公司能夠立即開始製造由 AI 設計、3D 打印的患者專屬植入物。SINTX 已收到醫生請求,為脊椎腫瘤切除後的骨科及神經外科腫瘤患者,提供人道使用的椎體替換(VBR)植入式儀器。此外,該公司打算運用 SiN/PEEK 複合材料,支援患者匹配及傳統減材製造植入式儀器的監管批准。 SINTX 主席、董事長暨行...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch